Bailey, Steven RSchool of Medicine |
|
| 7/2008 - Present | Chief of the Division of Cardiology | University of Texas Health Science at San Antonio, Medicine, San Antonio, TX |
| 4/2006 - Present | Distinguished Chair, Janey Briscoe | University of Texas Health Science Center, San Antonio, TX |
| 9/1999 - Present | Director, Janey Briscoe Center for Cardiovascular Research and Director | University of Texas Health Science Center, San Antonio, TX |
| 9/1997 - Present | Professor of Medicine | University of Texas Health Science Center at San Antonio, Medicine, San Antonio, TX |
| 9/1997 - Present | Professor of Radiology | University of Texas Health Science Center at San Antonio, Radiology, San Antonio, TX |
| 7/1990 - Present | Director, Interventional Fellowship Program | University of Texas Health Science Center at San Antonio, Medicine, San Antonio, TX |
| 9/1989 - Present | Director, Interventional Cardiology | University of Texas Health Science Center, Medicine, San Antonio, TX |
| Year | Degree | Discipline | Institution |
| 1983 | Postdoctoral Fellowship | Cardiovascular Fellowship | Fitzsimmons Army Medical Center Aurora , CO |
| 1981 | Residency | Internal Medicine | Fitzsimmons Army Medical Center Aurora , CO |
| 1981 | Residency | Internal Medicine Residency | Fitzsimmons Army Medical Center Aurora , CO |
| 1979 | Internship | Straight Medicine Internship | Fitzsimmons Army Medical Center Aurora , CO |
| 1978 | MD | Medicine | University of Oregon Health Science Center Portland , OR |
| 1973 | BA | Biology | University of Oregon Eugene , OR |
| Date | Description | Institution | # Students |
| 11/2005 - Present | Angiographic Peripheral Vascular Anatomy | ||
| 3/2005 - Present | Circulatory Assist Device | ||
| 3/2003 - Present | University of Texas Health Science Center at San Antonio | ||
| 9/2002 - Present | High School/Junior High School Student Supervision | University Hospital Cath Lab and University Health Science Center | |
| 5/2001 - Present | Grand Rounds- Graduate Level | University of Texas Health Science Center at San Antonio | |
| 8/1999 - Present | Interventional Cardiology Conference | University Hospital | 2 students |
| Tuesdays 7-8 AM. Responsible for organizing this conference. 2 exams per year. | |||
| 8/1992 - Present | Radiology Conference | University Hosptital | 10 students |
| Presents 4 times a year | |||
| 6/1992 - Present | Dental School Lecture- Graduate Level | University of Texas Health Science Center at San Antonio | |
| 5/1992 - Present | Graduate School- Post Graduate Level | University of Texas Health Science Center at San Antonio | |
| 1/1992 - Present | University of Texas Health Science Center at San Antonio | ||
| 5/1991 - Present | Rotation Student Supervision | University of Texas Health Science Center at San Antonio | |
| 1/1991 - Present | University of Texas Health Science Center at San Antonio | ||
| 5/1990 - Present | Medical School- Graduate Level | University of Texas Health Science Center at San Antonio | |
| 1/1990 - Present | University Hospital and VA Hospital | ||
| 1/1990 - Present | Membership on Supervising Committee | University Hospital | |
| 9/1989 - Present | Rotation Student Supervision | University Hospital and Veterans Hospital | |
| 8/1989 - Present | Cardiac Hemodynamics Conference | University Hospital | 15 students |
| Wednesday 7-8 AM. Responsible for organizing this conference. 2 exams per year | |||
| 8/1989 - Present | Rotation Student Supervision | University Hospital and Veterans Hospital | |
| 4/1989 - Present | Rotation Student Supervision | University of Texas Health Science Center at San Antonio | |
| 4/1989 - Present | University of Texas Health Science Center at San Antonio | ||
Journal Article |
| Russo AM, Stainback RF, Bailey SR, Epstein AE, Heidenreich PA, Jessup M, Kapa S, Kremers MS, Lindsay BD, Stevenson LW. ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhy Heart Rhythm 2013 Apr;10(4):11-58. |
| Hendel RC, Patel MR, Allen JM, Min JK, Shaw LJ, Wolk MJ, Douglas PS, Kramer CM, Stainback RF, Bailey SR, Doherty JU, Brindis RG. Appropriate use of cardiovascular technology: 2013 ACCF appropriate use criteria methodology update: a report of the American College of Cardiology Foundation appropriate use criteria task force J Am Coll Cardiol 2013 Mar;61(12):1305-1317. |
| Zhu B, Bailey SR, Mauli Agrawal C. Calcification of primary human osteoblast cultures under flow conditions using polycaprolactone scaffolds for intravascular applications J Tissue Eng Regen Med 2012 Oct;6:687-695. |
| Patel MR, Bailey SR, Bonow RO, Chambers CE, Chan PS, Dehmer GJ, Kirtane AJ, Samuel Wann L, Parker Ward R, Douglas PS, Patel MR, Bailey SR, Altus P, Barnard DD, Blankenship JC, Casey DE, Dean LS, Fazel R, Gilchrist IC, Kavinsky CJ, Lakoski SG, Le DE, Lesser JR, Levine GN, Mehran R, Russo AM, Sorrentino MJ, Williams MR, Wong JB, Wolk MJ, Bailey SR, Douglas PS, Hendel RC, Kramer CM, Min JK, Patel MR, Shaw L, Stainback RF, Allen JM. ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography an J Thorac Cardiovasc Surg 2012 Jul;144(1):39-71. |
| Patel MR, Bailey SR, Bonow RO, Chambers CE, Chan PS, Dehmer GJ, Kirtane AJ, Samuel Wann L, Parker Ward R, Douglas PS, Patel MR, Bailey SR, Altus P, Barnard DD, Blankenship JC, Casey DE, Dean LS, Fazel R, Gilchrist IC, Kavinsky CJ, Lakoski SG, Le DE, Lesser JR, Levine GN, Mehran R, Russo AM, Sorrentino MJ, Williams MR, Wong JB, Wolk MJ, Bailey SR, Douglas PS, Hendel RC, Kramer CM, Min JK, Patel MR, Shaw L, Stainback RF, Allen JM. ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography an J Thorac Cardiovasc Surg 2012 Jul;144(1):39-71. |
| Patel MR, Bailey SR, Bonow RO, Chambers CE, Chan PS, Dehmer GJ, Kirtane AJ, Samuel Wann L, Parker Ward R, Douglas PS, Patel MR, Bailey SR, Altus P, Barnard DD, Blankenship JC, Casey DE, Dean LS, Fazel R, Gilchrist IC, Kavinsky CJ, Lakoski SG, Le DE, Lesser JR, Levine GN, Mehran R, Russo AM, Sorrentino MJ, Williams MR, Wong JB, Wolk MJ, Bailey SR, Douglas PS, Hendel RC, Kramer CM, Min JK, Patel MR, Shaw L, Stainback RF, Allen JM. ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography an J Thorac Cardiovasc Surg 2012 Jul;144(1):39-71. |
| Patel MR, Dehmer GJ, Hirshfeld JW, Smith PK, Spertus JA, Masoudi FA, Dehmer GJ, Patel MR, Smith PK, Chambers CE, Ferguson TB, Garcia MJ, Grover FL, Holmes DR, Klein LW, Limacher MC, Mack MJ, Malenka DJ, Park MH, Ragosta M, Ritchie JL, Rose GA, Rosenberg AB, Russo AM, Shemin RJ, Weintraub WS, Wolk MJ, Bailey SR, Douglas PS, Hendel RC, Kramer CM, Min JK, Patel MR, Shaw L, Stainback RF, Allen JM. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and I J Thorac Cardiovasc Surg 2012 Apr;143(4):780-803. |
| Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography Catheter Cardiovasc Interv 2012 Feb;79(3):453-495. |
| Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions J Am Coll Cardiol 2011 Dec;58(24):44-122. |
| Zhu, Beili; Bailey,SR; Agrawal, Mauli. Engineering calcium deposits on polycaprolactone scaffolds for intravascular applications using primary human osteoblasts Tissue Engineering and Regenerative Medicine 2011 Apr;5(4):324-326. |
| Forbes G, Sorich E, Nath LC, Church S, Savage CJ, Bailey SR. Activin A as a novel biomarker of equine inflammatory abdominal disease: Preliminary findings Vet J 2011 Feb;. |
| Bailey SR. Women in interventions: a win for cardiovascular medicine Catheter Cardiovasc Interv 2010 Mar;75(4):648-650. |
| Cilingiroglu,M; Bailey SR. Effect of drug-eluting stents on endothelial dysfunction Interventional Cardiology 2010 Feb;2(1):45-56. |
| Kushner FG, Hand M, Smith SC, King SB, Anderson JL, Antman EM, Bailey SR, Bates ER, Blankenship JC, Casey DE, Green LA, Jacobs AK, Hochman JS, Krumholz HM, Morrison DA, Ornato JP, Pearle DL, Peterson ED, Sloan MA, Whitlow PL, Williams DO. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 gui Catheter Cardiovasc Interv 2009 Dec;74(7):25-68. |
| Klein LW, Sheldon MW, Brinker J, Mixon TA, Skelding K, Strunk AO, Tommaso CL, Weiner B, Bailey SR, Uretsky B, Kern M, Laskey W. The use of radiographic contrast media during PCI: a focused review: a position statement of the Society of Cardiovascular Angiography and Interventions Catheter Cardiovasc Interv 2009 Nov;74(5):728-746. |
| Robertson TP, Bailey SR, Peroni JF. Equine laminitis: a journey to the dark side of venous Vet Immunol Immunopathol 2009 Jun;129(3-4):164-166. |
| Brooks AC, Menzies-Gow NJ, Wheeler-Jones C, Bailey SR, Cunningham FM, Elliott J. Endotoxin-induced activation of equine digital vein endothelial cells: role of p38 MAPK Vet Immunol Immunopathol 2009 Jun;129(3-4):174-180. |
| Bailey SR, Adair HS, Reinemeyer CR, Morgan SJ, Brooks AC, Longhofer SL, Elliott J. Plasma concentrations of endotoxin and platelet activation in the developmental stage of oligofructose-induced laminitis Vet Immunol Immunopathol 2009 Jun;129(3-4):167-173. |
| Bailey SR. Neither horseshoes nor hand grenades--does close count in percutaneous coronary revascularization? Catheter Cardiovasc Interv 2008 Oct;72(4):457-458. |
| Slim AM, Sanghi P, Shry EA, Castillo-Rojas L, Alvarez J, Hernandez A, Conner WC, Erikson J, Bailey SR. Transcatheter cardiac fistula repair with the Amplatzer Duct Occluder: a case report and review J Interv Cardiol 2008 Jun;21(3):260-264. |
| Berhane Y, Bailey SR, Putignano C, Elliott J. Characterization of agonist-induced endothelium-dependent vasodilatory responses in the vascular bed of the equine digit J Vet Pharmacol Ther 2008 Feb;31(1):1-8. |
| Bailey SR. Histopathologic observations of femoral closure devices: understanding the differences Rev Cardiovasc Med 2008 Jan;9(1):21-28. |
| Bailey SR. Transcatheter Cardiac Fistula Repair with the Amplatzer duct Occluder: A case report and review Journal of Interventional Cardiology 2007 Nov;. |
| Patel DN, King C, Bailey SR, Kaliyamurthi Venkatachalam, Agrawal A, Valente AJ, Chandrasekar B,. Interleukin-17 stimulates C-reactive protein expression In hepatocytes and smooth muscle cells via p38 MAPK and ERK1/2-dependent NF-kB And C/EBPb activation J Biol Chem 2007 Sep;282:27229-27238. |
Book Chapter |
| Patel DN, Bailey SR. Nanotechnology - Will it revolutionize stent technology. In: Nabil Chafke, Bernard Durand, Jean Kretz. New Technologies in Vascular Biomaterials - Fundementals about Stents II. Strasbourg, France: Europort; 2007. p. 261-269. |
Abstract |
| B Zhu, Bailey SR, Agrawal CM. Human Osteoblast Culture on TGF-B Coated Polycaprolactone Scaffolds in Dexamethasone Conditioned Media; 2009 Jan. (Society for Biomaterials; vol. 31, no. 265). |
| B Zhu, Bailey SR, Agrawal CM. Calcification of Human Osteoblast Culture with TGF-B and Dexamethasone Treatments on Polycaprolactone Films; 2009 Jan. (Society for Biomaterials; vol. 31, no. 221). |
| Bailey SR. Calcification of Human Aortic Smooth Muscle Cell Cultures on GFas Plasma Treated Polyactic Acid Films; 2009 Jan. (Society for Biomaterials; vol. 31, no. 699). |
| Zhu B, Bailey SR, Agrawal CM. Polycaprolactone Scaffolds in Dexamethasone Conditioned Media; 2009 Jan. (Society For Biomaterials; vol. 31, no. 265). |
| Patel DN, Erikson JM, Bailey SR, Valente AJ, Chandrasekar B. Adiponectin Blocks IL-18-Mediated Endothelial Cell Death Through Activation of Akt and Suppression of NF-kB/PTEN Signaling; 2008 Jan. (Journal of the American College of Cardiology; vol. 51). |
| Colston JT, de la Rosa S, Bailey SR, Chandrasekar B. Novel Regulation of Wnt-Inducible Secreted Protein 1 by TNFa in Primary Human Cardiac Fibroblasts **In pess**; 2007 Nov. (Circulation). |
Editorial |
| Kern M, Applegate R, Bach RG, Bailey SR, Bashore TM, Bass TA, Bell M, de Bruyne B, Garratt KN, Jeremias A, Kereiakes DJ, Klein LW, Krucoff MW, Mintz GS, Morrison D, Ohman EM, Pichard A, Rosenfield K, Samady H, Stone GW, Tommaso C, Turi ZG, Uretsky B, Vetrovec G, Weiner BH, Welt F, Yeung AC. Conversation in cardiology: Should FFR and IVUS be counted as PCI? Catheter Cardiovasc Interv 2013 Feb;. |
Not Specified |
| Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions Circulation 2011 Dec;124(23):574-651. |
| Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography Circulation 2011 Dec;124(23):2574-2609. |
| Bailey SR. All in favor of radial percutaneous coronary intervention, raise your (patient''s) hand Catheter Cardiovasc Interv 2010 Jun;75(7):996-996. |
| Garratt KN, Bailey SR. Therapies for type 2 diabetes and coronary artery disease N Engl J Med 2009 Oct;361(14):1407-1408. |
| Cilingiroglu M, Elliott J, Sangi P, Matthews H, Tio F, Trauthen B, Elicker J, Bailey SR. In vivo evaluation of a biolimus eluting nickel titanium self expanding stent with overlapping balloon expandable drug eluting and bare metal stents in a porcine coronary model EuroIntervention 2009 Jan;4(4):534-541. |
| Bailey SR. "Neither horseshoes nor hand grenades"--does close count in percutaneous coronary revascularization? Catheter Cardiovasc Interv 2008 Oct;72(4):457-458. |
Private |
|
| Funding Agency | Myogen, Inc |
| Title | ARIES-1: Ambrisentan in PAH - A Phase III Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy Study of Ambrisentan in Subjects with Pulmonary Arterial Hypertension |
| Status | Active |
| Period | 5/2007 - Present |
| Role | Co-Investigator |
| Grant Detail | Goal: New endothelin receptor antagonist drug for treatment of pulmonary arterial hypertension. To evaluate the safety and efficacy of ambrisentan in treatment of pulmonary arterial hypertension |
| Funding Agency | Abbott Vascular |
| Title | SECURITY Carotid stent trial sub |
| Status | Active |
| Period | - Present |
| Role | Principal Investigator |
| Grant Detail | Underway at UHS and VA. |
State |
|
| Funding Agency | |
| Title | Myocardial Dysfunction in Type 2 Diabetes Mellitus (T2DM): Role of Intramyocellular Lipid Content and Mitochondrial Dysfunction in Myocardial Insulin Resistance and their Correction with Pioglitazone |
| Status | Active |
| Period | - Present |
| Role | Co-Investigator |
| Grant Detail | |
